XML 18 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Operating Partnership [Member]
Series B Preferred Operating Partnership [Member]
Series C Preferred Operating Partnership [Member]
Series D Preferred Operating Partnership [Member]
Common Operating Partnership [Member]
Other [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
General And Limited Partner, Operating Partnership [Member]
General And Limited Partner, Operating Partnership [Member]
Common Operating Partnership [Member]
Series D Preferred Stock [Member]
Preferred Partner [Member]
Series D Preferred Operating Partnership [Member]
Balance, beginning of period at Dec. 31, 2013 $ 1,931,895 $ 30,202 $ 33,568 $ 17,177 $ 0 $ 91,453 $ 1,025 $ 1,157 $ 1,973,159 $ 10,156 $ (226,002)      
Balance, beginning of period (in shares) at Dec. 31, 2013               115,755,527            
Issuance of common stock upon the exercise of options $ 3,095             $ 2 3,093          
Issuance of common stock upon the exercise of options (in shares) 211,747             211,747            
Restricted stock grants issued $ 1             $ 1            
Restricted stock grants issued (in shares)               117,370            
Restricted stock grants cancelled (in shares)               (23,595)            
Compensation expense related to stock-based awards 4,984               4,984          
Issuance of Operating Partnership units in conjunction with acquisitions 38,809   8,334 13,783 13,710 2,982     0          
Issuance of Preferred D Units in the Operating Partnership in conjunction with acquisitions                       $ (4,794) $ 0  
Redemption of Operating Partnership units for common stock 0 (10,240)       (398) 0 $ 3 10,635          
Redemption of Operating Partnership units for common stock (in shares)               299,190            
Issuance of common stock, net of offering costs               $ 0            
Issuance of common stock, net of offering costs (in shares)               0            
Redemption of Operating Partnership units for cash   (4,794)                        
Issuance of note receivable to Series C unit holders (20,230)     (20,230)                    
Net income 195,896 7,036 2,387 1,551 17 6,538 12       178,355      
Other comprehensive income (loss) (12,061) (74)       (347)       (11,640)        
Tax effect from vesting of restricted stock grants and stock option exercises 3,613               3,613          
Distributions to Operating Partnership units held by noncontrolling interests (19,081) (7,321) (2,386) (1,551) (17) (7,806)                
Distributions to other noncontrolling interests (53)           (53)              
Dividends paid on common stock at $2.93, $2.24 and $1.81 per share for the years ending December 31, 2016, 2015 and 2014, respectively (210,091)                   (210,091)      
Balance, end of period at Dec. 31, 2014 1,911,983 14,809 41,903 10,730 13,710 92,422 984 $ 1,163 1,995,484 (1,484) (257,738)      
Balance, end of period (in shares) at Dec. 31, 2014               116,360,239            
Issuance of common stock upon the exercise of options $ 1,542             $ 1 1,541          
Issuance of common stock upon the exercise of options (in shares) 79,974             79,974            
Restricted stock grants issued $ 2             $ 2            
Restricted stock grants issued (in shares)               174,558            
Restricted stock grants cancelled (in shares)               (18,090)            
Compensation expense related to stock-based awards 6,055               6,055          
Issuance of Operating Partnership units in conjunction with acquisitions 142,399         142,399                
Redemption of Operating Partnership units for common stock           (28,106)   $ 8 28,098          
Redemption of Operating Partnership units for common stock (in shares)               787,850            
Purchase of remaining equity interest in existing consolidated joint venture (1,268)           (822)   (446)          
Issuance of common stock, net of offering costs 446,877             $ 67 446,810          
Issuance of common stock, net of offering costs (in shares)               6,735,000            
Issuance of 2015 exchangeable senior notes - equity component 22,597               22,597          
Repurchase of equity portion of 2013 exchangeable senior notes (70,112)               (70,112)          
Net income 209,536 6,445 2,514 2,074 685 8,344         189,474      
Other comprehensive income (loss) (4,929) (15)       (46)       (4,868)        
Tax effect from vesting of restricted stock grants and stock option exercises 1,727               1,727          
Distributions to Operating Partnership units held by noncontrolling interests (24,503) (7,050) (2,515) (2,074) (685) (12,179)                
Dividends paid on common stock at $2.93, $2.24 and $1.81 per share for the years ending December 31, 2016, 2015 and 2014, respectively (269,302)                   (269,302)      
Balance, end of period at Dec. 31, 2015 $ 2,372,604 14,189 41,902 10,730 13,710 202,834 162 $ 1,241 2,431,754 (6,352) (337,566)      
Balance, end of period (in shares) at Dec. 31, 2015 124,119,531             124,119,531            
Issuance of common stock upon the exercise of options $ 1,444             $ 0 1,444          
Issuance of common stock upon the exercise of options (in shares) 97,855             97,855            
Restricted stock grants issued $ 2             $ 2            
Restricted stock grants issued (in shares)               119,931            
Restricted stock grants cancelled (in shares)               (9,947)            
Compensation expense related to stock-based awards 8,045               8,045          
Issuance of Operating Partnership units in conjunction with acquisitions 7,247         7,247                
Redemption of Operating Partnership units for sale of property (7,689)         (7,689)                
Issuance of Preferred D Units in the Operating Partnership in conjunction with acquisitions                           $ 67,193
Redemption of Operating Partnership units for common stock (506)         (1,083)     577          
Redemption of Operating Partnership units for common stock (in shares)               23,850            
Purchase of remaining equity interest in existing consolidated joint venture 0         800 (162)   (638)          
Issuance of common stock, net of offering costs 123,422             $ 14 123,408          
Issuance of common stock, net of offering costs (in shares)               1,381,300            
Repurchase of equity portion of 2013 exchangeable senior notes (872)             $ 2 (874)          
Repurchase of equity portion of 2013 exchangeable senior notes (in shares)               148,940            
Net income 397,089 7,645 2,514 2,570 1,971 16,262 0       366,127      
Other comprehensive income (loss) 24,598 201       1,275       23,122        
Tax effect from vesting of restricted stock grants and stock option exercises 2,404               2,404          
Distributions to Operating Partnership units held by noncontrolling interests (30,997) (7,650) (2,514) (2,570) (1,971) (16,292)                
Dividends paid on common stock at $2.93, $2.24 and $1.81 per share for the years ending December 31, 2016, 2015 and 2014, respectively (367,818)                   (367,818)      
Balance, end of period at Dec. 31, 2016 $ 2,596,166 $ 14,385 $ 41,902 $ 10,730 $ 80,903 $ 203,354 $ 0 $ 1,259 $ 2,566,120 $ 16,770 $ (339,257)      
Balance, end of period (in shares) at Dec. 31, 2016 125,881,460             125,881,460